Mark Andrew Ainsworth

7PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyAutoimmunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.

Emil Buhl, Mads Tjørnehøj Kraaer, Jens Kjeldsen

|Dec 26, 2025
MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).

Camilla Frimor, Casper Steenholdt, Ella Signe Kassandra Widigson

|Dec 24, 2025
Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review.

Frederikke Bindseil Culmsee-Holm, Emil Buhl, Mads Tjørnehøj Kraaer

|Oct 01, 2025
Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review.

Faria Sayed, Mark Andrew Ainsworth

|May 05, 2025
Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse.

Mark A Ainsworth, Camilla Frimor

|Nov 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations.

Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth

Pageof 2

Frequent Collaborators

3 joint publications

Casper Steenholdt

2 joint publications

Jens Kjeldsen

2 joint publications

Mads Tjørnehøj Kraaer

2 joint publications

Emil Buhl